Abiopharma

🔍 D LOREN ROBERT W (Director)

Company: XCel Brands, Inc. (XELB)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock at $0.955 per share (Direct)
  Date: 2026-08-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 795,216.00 | transaction_form_type: 4
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 1,742.00 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-26 | Code: H | nature_of_ownership: See Footnote | shares_owned_after: 60,731.00 | Footnotes: F2

Footnotes:

• F1: Represents shares held by Clearmarkets Capital, LLC (d/b/d IPX Capital, LLC), a company controlled by the reporting person.
• F2: Represents shares held by the Irrevocable Trust of Rose Dempsey, of which the reporting person has sole voting and dispositive power.